Navigation Links
Cynvec LLC(SM) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
Date:11/11/2008

NEW YORK, Nov. 11 /PRNewswire/ -- Cynvec LLC, a privately-held biopharmaceutical company focused on developing novel cancer therapies that harness the apoptotic ability of the Sindbis viral vector, today announced that executive management will participate in the Rodman & Renshaw 10th Annual Healthcare Conference to be held November 10 through November 12, 2008 at the New York Palace Hotel in New York City. Frank D. Stonebanks, President and Chief Executive Officer, is scheduled to present an overview of the company at 12:00 p.m. ET on Tuesday, November 11, 2008.

The presentation will be webcast live and archived on the company's website at http://www.cynvec.com.

About Cynvec LLC

Cynvec was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as standalone oncolytic therapeutics, delivery systems for monoclonal antibodies and cytokines as well as cancer diagnostic products. The Sindbis vector system, originally developed at NYU School of Medicine, represents a unique, patented platform technology for numerous commercial applications. The company is developing therapies to treat a number of tumor types, including ovarian, pancreatic, GI, liver, colorectal, and other cancers where the laminin receptor is overexpressed. The Company's lead product, CYN 101, is in late pre-clinical development, and has shown statistically significant survival rates in both ovarian and pancreatic cancer models. Further information on Cynvec can be found at http://www.cynvec.com.


'/>"/>
SOURCE Cynvec LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
2. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
3. Avicena Group to Present at Noble Financial Conference
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CEL-SCI to Present at the Noble Financial Conference
8. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Strategic Diagnostics Updates Roth Conference Presentation Time
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...EBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed that the U.S. Food and Drug Administration (FDA...ny,s PI3K/Akt pathway inhibitor compound, perifosi...ctory multiple myeloma. Keryx Biopharmaceuticals, ...
(Date:12/1/2009)...LINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/ ...y announced revenue guidance for the fourth quarte...lion, as compared with $69 million for the fourth ...esults was the first of two installment payments o...urth quarter 2008 results was a one-time $1.8 mill...
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To a...stry and to promote its potential, a group of indi...he Synthetic Biology Industry Association (SynBIA)...f the association is to provide a forum for indivi...industry, address its opportunities and its challe...
(Date:12/1/2009)...N FRANCISCO, Dec. 1 The Burrill Bi...f the value it lost in October. The Select,s gain ... month for the general markets with the Dow up 6.5...he gains held firm in the final two trading days o...h Thanksgiving holiday shopping and Dubai,s report...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...d in Indonesia, Thailand and Sri Lanka when the ch...lled the wealthier nations of the world stingy for...d off the remark as yet another reason to dislike ...have done, anyway: They opened their hearts and wa...able outpouring of private and corporate relief f...
...VoIP, may have found the missing link that would e...e a lot of telephone companies go into a state of ...paralyzed. , ,The telcos and cable companies are b...sue of delivering voice over the Internet and to b...evices. This enables them to provide the end-user ...
...ve Ophir Creek in Alaska. Credit: Alaska Division ... rural Alaskan knowledge can now spread globally t...nmental Remote Sensing Center and the Alaska Divis...MapTeach effort, or Mapping Technology Experience...combine geospatial information with traditional kn...
Other Biology Technology:Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3The day the old telephony died 2The day the old telephony died 3MapTeach project spreads Alaskan geographic knowledge online 2MapTeach project spreads Alaskan geographic knowledge online 3
(Date:12/2/2009)...s of carbon about a nanometer in diameterhave been...ultrastrong fibers, electrical wires in molecular ...ells. Thanks to a new development by researchers a...gy (NIST) and five partners, you can add one more ... of an aggressive form of breast cancer. , HER2 ...
(Date:12/2/2009)...cording to the National Institute of Health, 40 pe...abetes already have some stage of diabetic retinop...caused by leaky blood vessels, is a major cause of...he most feared diabetic complications. In fact, u...s for 10 years or more will experience some form o...
(Date:12/1/2009)...Dec. 1 GestureTek Inc. today annou...ey, portable, plug and play interactive projection...inment and touring promotions. GestureTek is the i...enabled gesture recognition technology for interac...ms. ,, Guaranteed for quality, the CUBE has TUV...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 1Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 3Regeneron Announces September 2009 Investment Conference Presentations 56871 1Regeneron Announces September 2009 Investment Conference Presentations 56871 2BayCare Outpatient Center Opens in Westchase Florida 56869 1
...researchers have used an experimental therapy in m...in a leading cause of inherited blindness. , The t...Research, involves injecting the eye with a bit of...lps disable the gene. , Normally the gene is es... of it are passed from generation to generation in...
...out of Africa some 60,000 years ago to populate th...he bacterium Helicobacter pylori, which causes gas... bacterium spread throughout the entire world. Thi...am of scientists led by Mark Achtman from the Max ...Germany. The researchers also discovered that diff...
... but they keep growing because they don,t react to...ers at Washington University School of Medicine in...ssenger into cancer cells that forces them to resp... the most sinister pathogens around ?HIV. , "HIV k...s of cells," says senior author William G. Hawkins...
Other Biology News:Gene therapy for blindness clears hurdle in mice 2Out of Africa -- Bacteria, as well 2HIV protein enlisted to help kill cancer cells 2HIV protein enlisted to help kill cancer cells 3
GIBCO Schneider's Drosophila Medium (1X) liquid from Invitrogen
Virology LabFax from Promega
GIBCO IPL-41 Insect Medium (1X) liquid from Invitrogen
GIBCO Newborn Calf Serum from Invitrogen
Biology Products: